Annual Total Long Term Liabilities
$14.91 M
+$151.00 K+1.02%
December 31, 2023
Summary
- As of February 26, 2025, BRNS annual total long term liabilities is $14.91 million, with the most recent change of +$151.00 thousand (+1.02%) on December 31, 2023.
- During the last 3 years, BRNS annual total long term liabilities has fallen by -$65.02 million (-81.34%).
- BRNS annual total long term liabilities is now -81.34% below its all-time high of $79.94 million, reached on December 1, 2020.
Performance
BRNS Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$14.16 M
-$214.00 K-1.49%
September 30, 2024
Summary
- As of February 26, 2025, BRNS quarterly total long term liabilities is $14.16 million, with the most recent change of -$214.00 thousand (-1.49%) on September 30, 2024.
- Over the past year, BRNS quarterly long term liabilities has stayed the same.
- BRNS quarterly long term liabilities is now -93.28% below its all-time high of $210.67 million, reached on March 1, 2021.
Performance
BRNS Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
BRNS Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.0% | 0.0% |
| 3 y3 years | -81.3% | -4.1% |
| 5 y5 years | -57.8% | +922.8% |
BRNS Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -12.3% | +1.0% | -21.9% | at low |
| 5 y | 5-year | -81.3% | +1.0% | -93.3% | +922.8% |
| alltime | all time | -81.3% | +1.0% | -93.3% | +922.8% |
Barinthus Biotherapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $14.16 M(-1.5%) |
| Jun 2024 | - | $14.37 M(-1.8%) |
| Mar 2024 | - | $14.63 M(-1.9%) |
| Dec 2023 | $14.91 M(+1.0%) | $14.91 M(-5.6%) |
| Sep 2023 | - | $15.80 M(-4.6%) |
| Jun 2023 | - | $16.55 M(+1.8%) |
| Mar 2023 | - | $16.26 M(+10.1%) |
| Dec 2022 | $14.76 M | $14.76 M(-14.7%) |
| Sep 2022 | - | $17.30 M(-4.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $18.12 M(+9.8%) |
| Mar 2022 | - | $16.50 M(-2.9%) |
| Dec 2021 | $17.00 M(-78.7%) | - |
| Dec 2021 | - | $17.00 M(+119.9%) |
| Sep 2021 | - | $7.73 M(+458.4%) |
| Jun 2021 | - | $1.38 M(-99.3%) |
| Mar 2021 | - | $210.67 M(+163.5%) |
| Dec 2020 | $79.94 M(+126.0%) | $79.94 M |
| Dec 2019 | $35.37 M | - |
FAQ
- What is Barinthus Biotherapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics annual total long term liabilities year-on-year change?
- What is Barinthus Biotherapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics quarterly long term liabilities year-on-year change?
What is Barinthus Biotherapeutics annual total long term liabilities?
The current annual total long term liabilities of BRNS is $14.91 M
What is the all time high annual total long term liabilities for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high annual total long term liabilities is $79.94 M
What is Barinthus Biotherapeutics annual total long term liabilities year-on-year change?
Over the past year, BRNS annual total long term liabilities has changed by +$151.00 K (+1.02%)
What is Barinthus Biotherapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of BRNS is $14.16 M
What is the all time high quarterly long term liabilities for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high quarterly total long term liabilities is $210.67 M
What is Barinthus Biotherapeutics quarterly long term liabilities year-on-year change?
Over the past year, BRNS quarterly total long term liabilities has changed by $0.00 (0.00%)